ARTICLE | Clinical News
KW-6002: Began Phase II trial
July 31, 2000 7:00 AM UTC
Kyowa Hakko Kogyo Co. Ltd., Tokyo, Japan Product: KW-6002 Business: Neurological Therapeutic category: Receptor antagonist Target: Adenosine A2 receptors Description: Adenosine A2 receptor antagonis...